Shahriar Minokadeh

Opinion author

Dr. Shahriar Minokadeh is a Johns Hopkins–trained anesthesiologist and UC San Diego–trained board-certified pain management specialist. Before his ALS diagnosis at 35 years old, he was practicing in Orange County, California, and now resides in San Diego. He is currently a quadriplegic who relies upon a ventilator to breathe. He used his eye-gaze device to write this. He is one of the petitioners in the ALS Citizens’ Petition (FDA-2025-P-2019).

Last month’s FDA advisory committee meetings for therapies developed by Capricor Therapeutics and Replimune effectively illustrate the different outcomes for patients when the agency prioritizes specialization in its reviews.